Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GuangZhou WeiShiBo Biotechnology is focused on research, development, manufacturing, and distribution of in vitro diagnostic reagents and devices. The company has developed a range of diagnostic products using advanced platforms such as time-resolved immunofluorescence chromatography and chemiluminescence. Clinical studies have been completed for multiple products across various disease areas including cardiovascular disease, cancer, diabetes, inflammation, maternity care, and kidney disease. The company holds patents for its technologies and has received regulatory approvals for some Class II medical device registration certificates in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GuangZhou WeiShiBo Biotechnology.